Article info
PDFElectronic pages
Correspondence response
Response to: ‘Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required’ by Moots et al
- Correspondence to Professor Paul Emery, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK; p.emery{at}leeds.ac.uk
Citation
Response to: ‘Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required’ by Moots et al
Publication history
- Accepted January 25, 2016
- First published February 17, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/